Chemical innovation and scaffold refinement in FDA-approved antibiotics (2015-2025).

Bonjorno AF, Boreski D, Fernandes GFS, Chin CM, Dos Santos JL

Open source

DOI
10.1016/j.ejmech.2026.119135
Published
2026 Nov 15
Container
European journal of medicinal chemistry
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ejmech.2026.119135,
  title = {Chemical innovation and scaffold refinement in FDA-approved antibiotics (2015-2025).},
  author = {Bonjorno AF and Boreski D and Fernandes GFS and Chin CM and Dos Santos JL},
  year = {2026},
  journal = {European journal of medicinal chemistry},
  doi = {10.1016/j.ejmech.2026.119135},
  url = {https://doi.org/10.1016/j.ejmech.2026.119135}
}

RIS

TY  - JOUR
TI  - Chemical innovation and scaffold refinement in FDA-approved antibiotics (2015-2025).
AU  - Bonjorno AF
AU  - Boreski D
AU  - Fernandes GFS
AU  - Chin CM
AU  - Dos Santos JL
PY  - 2026
JO  - European journal of medicinal chemistry
DO  - 10.1016/j.ejmech.2026.119135
UR  - https://doi.org/10.1016/j.ejmech.2026.119135
ER  - 

APA

AF, B., D, B., GFS, F., CM, C., & JL, D. S. (2026). Chemical innovation and scaffold refinement in FDA-approved antibiotics (2015-2025).. European journal of medicinal chemistry. https://doi.org/10.1016/j.ejmech.2026.119135

Source records